Late referral for about one in four neonates with critical CHD

Late referral for about one in four neonates with critical CHD

(HealthDay)—A considerable proportion of neonates with critical congenital heart disease (CCHD) are not referred to a cardiac center by age 4 days, according to a study published online June 30 in Pediatrics.

David E. Fixler, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues describe the correlation between timing of referral to a cardiac center and mortality in 2,360 neonates with CCHD, born before screening (1996 to 2007). The date of first at a cardiac center was used to ascertain the age at referral.

The researchers found that the median age at referral was 1 day, while 27.5 percent of neonates were referred after age 4 days, and no record of referral was found for 7.5 percent of neonates. For those referred at age 0 to 4 days, 5 to 27 days, and with no referral, was 18.1, 9.0, and 38.8 percent, respectively. Across two eras within 1996 to 2007, no improvement was seen in age at referral.

"A significant proportion of with CCHD experienced late or no referral to cardiac specialty centers, accounting for a significant number of the deaths," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Study examines drug labeling and exposure in infants

Dec 09, 2013

Federal legislation encouraging the study of drugs in pediatric patients has resulted in very few labeling changes that include new infant information, according to a study by Matthew M. Laughon, M.D., M.P.H., of the University ...

Recommended for you

An autoimmune response may contribute to hypertension

Sep 17, 2014

High blood pressure is a major risk factor for heart attack, stroke, chronic heart failure, and kidney disease. Inflammation is thought to promote the development of high blood pressure, though it is not clear what triggers ...

Results of RIBS IV trial reported

Sep 16, 2014

A new clinical trial comparing the use of everolimus-eluting stents (EES) and drug-eluting balloons (DEB) in treating in-stent restenosis (ISR) from drug-eluting stents found that EES provided superior late angiographic results ...

User comments